Annual report pursuant to Section 13 and 15(d)

License, Clinical Trial and Sponsored Research Agreements (Tables)

v3.20.1
License, Clinical Trial and Sponsored Research Agreements (Tables)
12 Months Ended
Dec. 31, 2019
License Agreements [Member]  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]  
Schedule of license, clinical trial and sponsored research agreements

 

 

 

 

 

 

 

 

 

For the year ended December 31, 

($ in thousands)

    

2019

    

2018

City of Hope

 

 

  

 

 

  

CD123

 

$

250

 

$

 —

CS1

 

 

200

 

 

 —

PSCA

 

 

200

 

 

 —

HER2

 

 

 —

 

 

200

Manufacturing

 

 

 —

 

 

75

CSL Behring (Calimmune)

 

 

200

 

 

 —

UCLA

 

 

300

 

 

 —

St. Jude - XSCID

 

 

 —

 

 

1,000

Nationwide Children's Hospital - C134

 

 

200

 

 

 —

Fortress PIK Dividend

 

 

4,923

 

 

2,085

Total

 

$

6,273

 

$

3,360

 

Sponsored Research And Clinical Trial Agreements [Member]  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]  
Schedule of license, clinical trial and sponsored research agreements

 

 

 

 

 

 

 

 

 

For the year ended December 31, 

($ in thousands)

    

2019

    

2018

City of Hope

 

$

2,000

 

$

2,000

City of Hope - CD123

 

 

1,202

 

 

835

City of Hope - IL13Rα2

 

 

876

 

 

1,056

City of Hope - Manufacturing

 

 

457

 

 

458

Fred Hutch - CD20

 

 

762

 

 

1,301

St. Jude - XSCID

 

 

777

 

 

 —

BIDMC - CRISPR

 

 

69

 

 

69

Total

 

$

6,143

 

$

5,719